Moderna is under fire after financial records showed the biotech company’s CEO Stephane Bancel earned around $393 million in 2022 from stock options he exercised as he received a 50% raise.
Bancel, whose firm is known for producing the COVID-19 vaccine, received $1.5 million in 2022, an increase of 50% from 2021, and Moderna increased his target cash bonus, a March securities and exchange commission filing shows.
Read More